The Effects of Anti-Diabetic Drugs on LDL Subclasses: Any Role for Colesevelam?

被引：0
作者：
Rizzo, Manfredi [1 ]
Mikhailidis, Dimitri P. [2 ]
Al-Rasadi, Khalid [3 ]
机构：
[1] Univ Palermo, Biomed Dept Internal Med & Med Specialties, I-90127 Palermo, Italy
[2] Univ Coll London UCL, Univ Coll London Med Sch, Dept Clin Biochem, Vasc Dis Prevent Clin, London, England
[3] Sultan Qaboos Univ Hosp, Dept Clin Biochem, Muscat, Oman
来源：
CARDIOVASCULAR DRUGS AND THERAPY | 2014年 / 28卷 / 03期
关键词：
LIPOPROTEIN PARTICLES; CLINICAL-SIGNIFICANCE; TYPE-2; RISK; ROSIGLITAZONE; PIOGLITAZONE; THERAPY; SIZE; LIRAGLUTIDE; METFORMIN;
D O I：
10.1007/s10557-014-6521-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：205 / 207
页数：3
相关论文
共 25 条
[1]  
[Anonymous], GUID IND DIAB MELL E
[2]   Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes [J].
Berneis, Kaspar ;
Rizzo, Manfredi ;
Stettler, Christoph ;
Chappuis, Bernard ;
Braun, Monica ;
Diem, Peter ;
Christ, Emanuel R. .
EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (03) :343-349
[3]   Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers [J].
Chiquette, Elaine ;
Toth, Peter P. ;
Ramirez, Gilbert ;
Cobble, Michael ;
Chilton, Robert .
VASCULAR HEALTH AND RISK MANAGEMENT, 2012, 8 :621-629
[4]   Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes [J].
Chu, NV ;
Caulfield, M ;
Kong, APS ;
Mudaliar, SR ;
Kim, DD ;
Reitz, R ;
Armstrong, D ;
Henry, RR ;
Baxi, S ;
Reaven, PD ;
Deutsch, R .
DIABETES CARE, 2002, 25 (03) :542-549
[5]   Potential Anti-Atherosclerotic Effects of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus [J].
Dhindsa, Sandeep ;
Jialal, Ishwarlal .
CURRENT DIABETES REPORTS, 2014, 14 (02)
[6]   A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia [J].
Goldberg, RB ;
Kendall, DM ;
Deeg, MA ;
Buse, JB ;
Zagar, AJ ;
Pinaire, JA ;
Tan, MH ;
Khan, MA ;
Perez, AT ;
Jacober, SJ .
DIABETES CARE, 2005, 28 (07) :1547-1554
[7]   Initial combination therapy with metformin plus colesevelam improves lipoprotein particles in patients with early type 2 diabetes mellitus [J].
Goldberg, Ronald B. ;
Rosenson, Robert S. ;
Hernandez-Triana, Eric ;
Misir, Soamnauth ;
Jones, Michael R. .
JOURNAL OF CLINICAL LIPIDOLOGY, 2012, 6 (04) :318-324
[8]   Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies [J].
Hayashi, Toshiyuki ;
Hirano, Tsutornu ;
Yamamoto, Takeshi ;
Ito, Yasuki ;
Adachi, Mitsuru .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (07) :879-884
[9]   Small Dense Low-Density Lipoprotein-Cholesterol Concentrations Predict Risk for Coronary Heart Disease The Atherosclerosis Risk in Communities ( ARIC) Study [J].
Hoogeveen, Ron C. ;
Gaubatz, John W. ;
Sun, Wensheng ;
Dodge, Rhiannon C. ;
Crosby, Jacy R. ;
Jiang, Jennifer ;
Couper, David ;
Virani, Salim S. ;
Kathiresan, Sekar ;
Boerwinkle, Eric ;
Ballantyne, Christie M. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34 (05) :1069-1077
[10]   Lipids and lipoproteins in patients with type 2 diabetes [J].
Krauss, RM .
DIABETES CARE, 2004, 27 (06) :1496-1504
123